Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis

Vickerman, PHickman, MMay, MKretzschmar, MWiessing, L2025-03-202025-03-2020101992251510.1111/j.1360-0443.2009.02759.xhttps://rivm.openrepository.com/handle/10029/644200Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysisArticleAddiction 2010; 105(2):311-82025-03-20